-
Making Sense of Antisense: The Power of Gene Silencing
Suzanne Elvidge
February 11, 2025
This article explores antisense oligonucleotides (ASOs) in gene silencing, covering their mechanism, development, applications, pros and cons, and future delivery challenges.
-
ST Pharm to construct second oligonucleotide facility in Korea
CPhIonline
December 03, 2021
The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025.
-
Hoth Therapeutics and WuXi strike API and drug product deal for cancer therapeutic
CPhIonline
November 15, 2021
WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide.
-
Hoth Therapeutics, WuXi STA Ink API and Drug Product Pact
ContractPharma
November 10, 2021
Hoth Therapeutics, Inc., a biopharmaceutical company, has entered into two contracts with STA Pharmaceutical, a subsidiary of WuXi AppTec (WuXi STA), for process development and manufacturing...
-
Asymchem Expands Oligonucleotides Mfg. Capacity
contractpharma
March 29, 2021
API facility in Tianjin, China will accommodate gram to ton production scales with capacity to accommodate 12 or more oligo process production lines.
-
UK to revolutionise oligonucleotide medicines manufacturing
europeanpharmaceuticalreview
February 25, 2021
Collaborators on Grand Challenge 3 will utilise their combined expertise to transform the oligonucleotide supply chain.